Cantor Fitzgerald restated their overweight rating on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a research report report published on Wednesday, Benzinga reports. Separately, HC Wainwright reaffirmed a buy rating and issued a $59.00 price objective on shares of Belite Bio in a research report on Friday, March 22nd. Seven analysts have rated […]
Belite Bio (NASDAQ:BLTE) Receives Overweight Rating from Cantor Fitzgerald
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Belite Bio Reports First-Quarter 2024 Financial Results and
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
BLTE Stock Earnings: Belite Bio Misses EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.